ERIS LIFESCIENCES
Back to Cashflow Statement
|
ERIS LIFESCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-881 Cr | ₹1,380 Cr | ₹688 Cr | ₹-45 Cr | ₹-82 Cr |
What is the latest Cash Flow from Financing Activities ratio of ERIS LIFESCIENCES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-881 Cr |
| Mar2024 | ₹1,380 Cr |
| Mar2023 | ₹688 Cr |
| Mar2022 | ₹-45 Cr |
| Mar2021 | ₹-82 Cr |
How is Cash Flow from Financing Activities of ERIS LIFESCIENCES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-881 Cr | Negative | |
| Mar2024 | ₹1,380 Cr | 100.53 | |
| Mar2023 | ₹688 Cr | Positive | |
| Mar2022 | ₹-45 Cr | Negative | |
| Mar2021 | ₹-82 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹18,179.5 Cr | -1% | -8.1% | -25.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | -0% | -4.5% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5.9% | 16.1% | 49.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | 3% | 3% | 34% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -0.4% | -3.6% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | NA | 2.8% | -7.1% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -1% |
-8.1% |
-25.3% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses